Literature DB >> 7994041

Changes in cytokine secretion patterns of CD4+ T-cell clones in human immunodeficiency virus infection.

L Meyaard1, S A Otto, I P Keet, R A van Lier, F Miedema.   

Abstract

In addition to the loss of CD4+ T cells in later stages of human immunodeficiency virus (HIV) infection, functional defects of Th cells can already be observed in early infection. Decreased interleukin (IL)-2 and interferon (IFN)-gamma production by CD4+ T cells and diminished delayed type hypersensitivity reactions are indicative for impaired Th1 responses. We studied the cytokine secretion patterns of T-cell clones (TCC) generated by mitogenic stimulation of CD4+ memory T cells. Compared with TCC from HIV-negative controls, TCC isolated from HIV-infected individuals consistently showed increased IL-4 production, often paralleled by increased IL-5 and decreased IFN-gamma production. This resulted in a decreased percentage of Th1 clones with an increase in Th0 clones. To rule out the influence of interindividual differences, we studied two individuals from whom cells were available before and after infection with HIV. Indeed, an increase in Th2 cytokine secretion was observed after HIV-infection. Loss of Th1 and enhanced Th2 responses might further curtail cellular responses resulting in deficiency of cellular immunity in HIV infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7994041

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression.

Authors:  A Valentin; W Lu; M Rosati; R Schneider; J Albert; A Karlsson; G N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

2.  Bereavement is associated with time-dependent decrements in cellular immune function in asymptomatic human immunodeficiency virus type 1-seropositive homosexual men.

Authors:  K Goodkin; D J Feaster; R Tuttle; N T Blaney; M Kumar; M K Baum; P Shapshak; M A Fletcher
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

Review 3.  Molecular immunopathogenesis of HIV infection.

Authors:  T T Ng; A J Pinching; C Guntermann; W J Morrow
Journal:  Genitourin Med       Date:  1996-12

Review 4.  Immune dysregulation and CD4+ T cell loss in HIV-1 infection.

Authors:  L Meyaard; F Miedema
Journal:  Springer Semin Immunopathol       Date:  1997

5.  Reciprocal modulatory interaction between human immunodeficiency virus type 1 Tat and transcription factor NFAT1.

Authors:  F Macián; A Rao
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 6.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

7.  Modulation of T cell responses to recall antigens presented by Langerhans cells in HIV-discordant identical twins by anti-interleukin (IL)-10 antibodies and IL-12.

Authors:  A Blauvelt; C Chougnet; G M Shearer; S I Katz
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

8.  Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques.

Authors:  A A Ansari; A E Mayne; J B Sundstrom; P Bostik; B Grimm; J D Altman; F Villinger
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

9.  HIV-induced IL-6/IL-10 dysregulation of CD4 cells is associated with defective B cell help and autoantibody formation against CD4 cells.

Authors:  R Weimer; S Zipperle; V Daniel; R Zimmermann; K Schimpf; G Opelz
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

10.  Fas (CD95) expression and death-mediating function are induced by CD4 cross-linking on CD4+ T cells.

Authors:  J Desbarats; J H Freed; P A Campbell; M K Newell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.